Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by AstraZeneca Pharmaceuticals (Ireland) DAC naming John Lahart .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Rare disease policy and access to medicines (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Programme for Government priorities and rare disease medicines access policy (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meetings to discuss equity of access to oncology treatments (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Engagement regarding access to orphan medicines and national rare disease plan (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2023 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 7 | On lobbying.ie |
| Sep–Dec 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 10 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 7 | 100.0% |